Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porters Five Force Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Eicosapentanoic Acid (EPA)
5.1.2 Docosahexaenoic Acid (DHA)
5.1.3 EPA/DHA
5.2 By Application
5.2.1 Food and Beverages
5.2.1.1 Infant Formula
5.2.1.2 Fortified Food and Beverages
5.2.2 Dietary Supplements
5.2.3 Pharmaceuticals
5.2.4 Animal Nutrition
5.2.5 Clinical Nutrition
5.3 By Concentration Type
5.3.1 High Concentrated
5.3.2 Medium Concentrated
5.3.3 Low Concentrated
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.1.4 Rest of North America
5.4.2 Europe
5.4.2.1 Spain
5.4.2.2 United Kingdom
5.4.2.3 Germany
5.4.2.4 France
5.4.2.5 Italy
5.4.2.6 Russia
5.4.2.7 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 Rest of Asia-Pacific
5.4.4 South America
5.4.4.1 Brazil
5.4.4.2 Argentina
5.4.4.3 Rest of South America
5.4.5 Middle East and Africa
5.4.5.1 South Africa
5.4.5.2 United Arab Emirates
5.4.5.3 Rest of Middle East and Africa


6 COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Strategies Adopted by Leading Players
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 Archer Daniels Midland Company
6.4.2 Koninklijke DSM N.V.
6.4.3 Corbion N.V.
6.4.4 Neptune Wellness Solutions
6.4.5 Source Omega LLC
6.4.6 Polaris
6.4.7 BASF SE
6.4.8 Novotech Nutraceuticals Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS